To what extent does the number of mast cells at a particular site and their responsiveness to triggers such as pressure, allergens or MRGPRX2 agonists affect the occurrence of HAE-C1-INH attacks at that site? This evidence concerns the gene MRGPRX2 and hereditary angioedema.